1. Home
  2. CLNN
Logo Clene Inc.

CLNN

Clene Inc.

as 09-17-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Founded: 2012 Country:
United States
United States
Employees: N/A City: SALT LAKE CITY
Market Cap: 57.9M IPO Year: N/A
Target Price: $32.67 AVG Volume (30 days): 117.0K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.57 EPS Growth: N/A
52 Week Low/High: $2.28 - $7.10 Next Earning Date: 11-12-2025
Revenue: $286,000 Revenue Growth: -35.29%
Revenue Growth (this year): -42.98% Revenue Growth (next year): 2178.18%

CLNN Daily Stock ML Predictions

Share on Social Networks: